Category: women’s health

Ripple Effects of Abortion Restrictions Confuse Care for Miscarriages

In Texas, where anyone can face a hefty fine of at least $10,000 if they abet an abortion, medical professionals on the front lines face tough quandaries when treating patients who have a miscarriage, a scenario that could soon play out around the country if abortion restrictions tighten.

KHN’s ‘What the Health?’: Leaked Abortion Opinion Rocks Washington’s World

The unprecedented early leak of a Supreme Court draft opinion that would overturn the landmark abortion-rights ruling Roe v. Wade has heated the national abortion debate to boiling. Meanwhile, the FDA, after years of consideration, moves to ban menthol flavors in cigarettes and cigars. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Shefali Luthra of the 19th, and Jessie Hellmann of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Paula Andalo, who wrote the latest KHN-NPR “Bill of the Month” episode about a family whose medical debt drove them to seek care south of the border.

Even When IVF Is Covered by Insurance, High Bills and Hassles Abound

Only 15 states require insurance to cover in vitro fertilization, a common path to parenthood for people who have trouble getting pregnant. And even for those whose insurance covers IVF, the expensive procedures and required drugs can lead to unexpected bills.

What’s Next If ‘Roe v. Wade’ Falls? More Than Half of States Expected to Ban or Restrict Abortion

If the Supreme Court affirms the leaked draft decision and overturns abortion rights, the effects would be sweeping in states where Republican-led legislatures have been eagerly awaiting the repudiation of a woman’s right to terminate a pregnancy.

Historic ‘Breach’ Puts Abortion Rights Supporters and Opponents on Alert for Upcoming Earthquake

An opinion published by Politico confirms what many who have followed the abortion debate already suspected: Roe v. Wade is soon to be no more. But the question remains: How will the public respond?

KHN’s ‘What the Health?’: More Covid Complications for Congress

Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN’s Julie Rovner to discuss these issues and more.

Emergency Contraception Marks a New Battle Line in Texas

In the shadow of Texas’ austere abortion regulations, grassroots organizers employ stealth tactics to help young women get emergency contraception.

Abortion Clinic on Texas-Mexico Border Faces Unique Legal and Cultural Challenges

Just as Texas has tightened its laws surrounding abortion, Mexico has gone the opposite direction, compelling people to seek potentially less-safe procedures south of the border.

KHN’s ‘What the Health?’: News You Might Have Missed

Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

KHN’s ‘What the Health?’: News You Might Have Missed

Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.